vancomycin has been researched along with lactoferrin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Leitch, EC; Willcox, MD | 2 |
Gutteberg, TJ; Osbakk, SA; Perstølen, T; Rekdal, O; Svendsen, JS; Ulvatne, H; Vorland, LH | 1 |
Choi, SY; Ghosh, P; Iqbal, H; Kim, EH; Kim, GL; Kwon, H; Le, NT; Lee, S; Park, SS; Pyo, S; Rhee, DK; Seon, SH; Tran, TD | 1 |
Connell, S; Fukuda, S; Imada, T; Kawashima, M; Nakamura, S; Tsubota, K; Yamamoto, H | 1 |
5 other study(ies) available for vancomycin and lactoferrin
Article | Year |
---|---|
Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin.
Topics: Anti-Bacterial Agents; Biofilms; Contact Lenses, Hydrophilic; Drug Synergism; Lactoferrin; Muramidase; Staphylococcus epidermidis; Vancomycin | 1999 |
Interference of the antimicrobial peptide lactoferricin B with the action of various antibiotics against Escherichia coli and Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Cattle; Drug Interactions; Drug Synergism; Erythromycin; Escherichia coli; Gentamicins; Lactoferrin; Microbial Sensitivity Tests; Penicillin G; Staphylococcus aureus; Vancomycin | 1999 |
Lactoferrin-induced reduction of vanB vancomycin resistance in enterococci.
Topics: Cell Wall; Culture Media; Drug Resistance, Bacterial; Enterococcus faecium; Lactic Acid; Lactoferrin; Microbial Sensitivity Tests; Vancomycin | 2001 |
Induction of the pneumococcal vncRS operon by lactoferrin is essential for pneumonia.
Topics: A549 Cells; Animals; Bacterial Proteins; Cytokines; Humans; Immunity, Innate; Inflammation; Lactoferrin; Lung; Male; Mice, Nude; Mutation; Operon; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Transferrin; Vancomycin; Virulence | 2018 |
Lactoferrin Ameliorates Dry Eye Disease Potentially through Enhancement of Short-Chain Fatty Acid Production by Gut Microbiota in Mice.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cytokines; Disease Models, Animal; DNA, Bacterial; Dry Eye Syndromes; Fatty Acids, Volatile; Female; Gastrointestinal Microbiome; Inflammation; Lactoferrin; Mice; Mice, Inbred C57BL; Protective Agents; Signal Transduction; Tears; Treatment Outcome; Vancomycin | 2021 |